World News – UK – Mexico signs contract with Pfizer to supply Covid-19 vaccine

Reuters |
MEXICO CITY
Last updated on 2. December 2020 at 11:10 am

MEXICO CITY (Reuters) – The Mexican government should sign a contract with pharmaceutical company Pfizer on Wednesday for the delivery of its coronavirus vaccine, Deputy Health Secretary Hugo Lopez-Gatell said Tuesday.

Pfizer has given the details of its vaccine to Mexico’s Cofepris health authority, and the country’s foreign minister said last month the government expects the vaccine to reach Mexico in December. document. write («  »); googletag. cmd. push (function () {googletag. defineOutOfPageSlot (‘/ 6516239 / outofpage_1x1_desktop’, ‘div-gpt-ad-1490771277198-0’). addService (googletag. pubads ()); googletag. Pubads (). enableSyncRendering (); googletag. enableServices ();});

Lopez-Gatell said the contract with Pfizer, which developed its vaccine with German partner BioNTech SE, is expected to be signed by Minister of Health Jorge Alcocer, and the Treasury Department plans to ensure Mexico has enough money to pay for Pfizer and provide other vaccines.

Mexico’s contract with Pfizer will include ways to minimize the challenges associated with its vaccine, which require shipping and storage at -70 degrees Celsius. .

« The contract, which will be signed tomorrow, provides that it will be distributed so close to the point of use that it will shorten the freezing time and reduce the distance traveled, » said Lopez-Gatell.

Lopez-Gatell also said the Janssen division of Johnson & Johnson started its clinical trial of the coronavirus in Mexico, where up to 20. 000 subjects are expected.

The Mexican Ministry of Health reported on Tuesday 8. 819 new confirmed cases of coronavirus infections and 825 additional deaths bringing the total to 1 in the country. 122. 362 cases and 106. 765 deaths increased.

The government says the actual number of people infected is likely significantly higher than the confirmed cases.

(It is possible that only the headline and image of this report have been revised by the Business Standard staff. The rest of the content is automatically generated from a syndicated feed. )

Business Standard has always endeavored to provide updated information and commentary on developments that are of interest to you and have a wider political and economic impact on the country and the world. Your encouragement and constant feedback to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these troubled times resulting from Covid-19, we continue to strive to keep you updated with credible news, authoritative views, and concise comments on relevant topics.
However, we have a request.

As we struggle against the economic impact of the pandemic, we need your support even more so that we can continue to provide you with higher quality content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. A larger subscription to our online content can only help us achieve our goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital editor

Business Standard would be happy to inform you about the introduction of « Business Standard Premium Services »

As a Premium subscriber, you get unrestricted access to a range of services across all devices, including:

Welcome to Business Standard Premium Services, courtesy of FIS.
Please visit the Manage My Subscription page to discover the benefits of this program.
Have fun while reading!
Team Business Standard

Vaccine, Pfizer, Coronavirus, Mexico, Pharmaceutical Industry, Hugo López-Gatell Ramírez